Skip to content
  • My Profile
  • Register
  • Log In
  • Watchlist
AlphaStreet

Market Intelligence Ecosystem

  • News
          • Technology
          • Consumer
          • Health Care
          • Industrials
          • Retail
          • Finance
          • Energy
          • IPO
          • Leisure & Entertainment
          • Research Summary
          • Other Industries
  • News
    • Consumer
    • Energy
    • Finance
    • Health Care
    • Industrials
    • IPO
    • Leisure & Entertainment
    • Other Industries
    • Research Summary
    • Retail
    • Technology
  • AlphaGraphs
  • AlphaStreet Intelligence
  • Log In
  • Register
  • My Profile
  • Watchlist

Categories

  • CEO Insights
  • Fund Manager Insights
  • Concall Highlights
  • Analysis
  • Concall Transcripts
  • AlphaGraphs

pharmaceuticals

Laurus Labs Ltd Q4FY25; 211% rise in Profits

June 5, 2025

Founded in 2005, Laurus Labs is a research-driven pharmaceutical and biotechnology company having a global leadership position in select Active Pharmaceutical Ingredients

Akums Drugs & Pharmaceuticals Ltd Q4FY25; 12% rise in Revenue

June 5, 2025

Established in 2004, Akums Drugs and Pharmaceuticals Limited is a pharmaceutical contract development and manufacturing organization (CDMO) offering a comprehensive range of

Jubilant Pharmova Ltd Q4FY25; 10% rise in Revenue

June 4, 2025

Jubilant Pharmova Ltd is an integrated global pharmaceuticals company having three business segments i.e. pharmaceuticals, contract research and development services and proprietary

Sun Pharmaceutical Industries Ltd Q4FY25; 19% fall in Profits

May 23, 2025

Sun Pharmaceutical Industries Ltd is engaged in the business of manufacturing, developing and marketing a wide range of branded and generic formulations

Zydus Lifesciences Ltd Q4FY25; 0% fall in Profits

May 21, 2025

In 1995, the group was restructured and thus was formed Cadila Healthcare under the aegis of the Zydus group. From a humble

Suven Pharmaceuticals Ltd Q3FY25; 77% rise in Profits

March 25, 2025

Hyderabad based CDMO company that offers services to leading global pharmaceutical and fine chemical majors in their NCE development endeavours. From process

Piramal Pharma Ltd Q3FY25; 64% fall in Profits

March 10, 2025

Piramal Pharma Limited (PPL) is part of the Piramal group of companies. The company operates through 3 major segments (1) Contract development

J B Chemicals & Pharmaceuticals Ltd Q3FY25; 21% rise in Profits

February 25, 2025

J.B. Chemicals and Pharmaceuticals Limited, established in 1976, is one of India's leading pharmaceutical companies. An integrated, publicly-listed organization with a focus

Mankind Pharma Ltd Q3FY25; 15% fall in Profits

February 17, 2025

Incorporated in 1995, Mankind Pharma Limited develops, manufactures, and markets pharmaceutical formulations in various acute and chronic therapeutic areas and several consumer

Lupin Ltd Q3FY25; 39% rise in Profits

February 12, 2025

Lupin is an innovation-led transnational pharmaceutical company headquartered in Mumbai. Lupin develops and commercializes a wide range of branded and generic formulations,

Laurus Labs Ltd Q3FY25; 304% rise in Profits

February 11, 2025

Founded in 2005, Laurus Labs is a research-driven pharmaceutical and biotechnology company having a global leadership position in select Active Pharmaceutical Ingredients

Glenmark Pharmaceuticals Ltd Q3FY25; 16% fall in Profits

February 5, 2025

Glenmark Pharmaceuticals Ltd is a global research-led pharmaceutical company with presence across generics, Specialty and OTC business with operations in over 80

Ipca Laboratories Ltd Q2FY25; 81% rise in Profits

January 3, 2025

Ipca Laboratories is engaged in the manufacturing and marketing of pharmaceuticals. Financial Results: Ipca Laboratories Ltd reported Revenues for Q2FY25 of ₹2,355.00

Cipla Ltd Q2FY25; 13% rise in Profits

November 13, 2024

Cipla is engaged in the Business of Pharmaceuticals.(Source : 202003 Annual Report Page No:157) Financial Results: Cipla Ltd reported Revenues for Q2FY25

J B Chemicals & Pharmaceuticals Ltd Q2FY25; 16% rise in Profits

November 7, 2024

J.B. Chemicals and Pharmaceuticals Limited, established in 1976, is one of India's leading pharmaceutical companies. An integrated, publicly-listed organization with a focus

Torrent Pharmaceuticals Ltd Q2FY25; 17% rise in Profits

November 4, 2024

Torrent Pharmaceuticals Ltd is one of the leading Indian Pharmaceutical Company engaged in research, development, manufacturing and marketing of generic pharmaceutical formulations.

Strides Pharma Science Ltd Q1FY24; 1% fall in Revenue

October 3, 2024October 3, 2024

Strides Pharma Science Ltd is in the business of development and manufacturing of pharmaceutical products. The company's pharmaceutical products are sold in

Zydus Lifesciences Ltd Q1FY24; 97% rise in Profits

September 18, 2024September 18, 2024

In 1995, the group was restructured and thus was formed Cadila Healthcare under the aegis of the Zydus group. From a humble

Suven Pharmaceuticals Ltd Q1FY25; 50% fall in Profits

September 3, 2024September 3, 2024

Hyderabad based CDMO company that offers services to leading global pharmaceutical and fine chemical majors in their NCE development endeavours. From process

Wanbury Ltd.: Strategic Growth in High-Demand Therapeutic Areas and Expanding Global Reach

August 29, 2024August 29, 2024

Company Overview Wanbury Ltd. is an Indian pharmaceutical company engaged in the manufacture and distribution of active pharmaceutical ingredients (APIs) and formulations.

Sun Pharmaceuticals Industries Ltd Q1FY25; 43% rise in Profits

August 28, 2024August 28, 2024

Sun Pharmaceutical Industries Ltd is engaged in the business of manufacturing, developing and marketing a wide range of branded and generic formulations

Posts navigation

Older posts

© 2020 AlphaStreet Inc. All Rights Reserved

Quick Links

  • AlphaGraphs
  • Earnings Transcripts
  • Earnings Calls
  • Contact
  • Company
  • The Team

Contact Info

info@alphastreet.com

44053 Fremont Blvd,
Fremont, CA 94538

Top